Sudeep Pharma Limited - IPO

MAINBOARD

Sudeep Pharma IPO Details

Open Date

Close Date

Listing Date

Issue Price

₹0 - ₹0

Face Value

₹1 per share

Lot Size

GMP

₹0

Issue Type

IPO

Listing On

NSE, BSE

Type

Book Built Issue

Share holding pre issue

Share holding post issue

Total Issue Size

Fresh Issue

Offer for Sale

1,00,76,492 shares (aggregating up to ₹0.00 Cr)

DRHP Status

Filed With SEBI

Sudeep Pharma IPO Lot Size

Application	Lots	Shares	Amount
To be announced

Sudeep Pharma IPO Reservation

Promoter Holding

Pre Issue:-

Post Issue:-

Documents

› Sudeep Pharma IPO DRHP

Sudeep Pharma IPO Valuations

ROE:37.40%

ROCE:41.18%

DEBT/EQUITY:0.17

RONW:37.08%

PAT MARGIN:28.99%

Sudeep Pharma Limited Financial Information

Period Ended	31 Dec 2024	31 Mar 2024	31 Mar 2023	31 Mar 2022
Assets	656.92	513.87	420.11	345.00
Revenue	350.02	465.38	438.26	351.00
Profit After Tax	94.54	133.15	62.32	49.80
EBITDA	136.74	187.76	98.64	75.15
Net Worth	453.36	359.07	226.29	163.92
Reserves and Surplus	437.75	354.59	221.88	161.40
Total Borrowing	117.20	75.03	82.26	83.71
Amount in ₹ Crore

About Sudeep Pharma IPO

Incorporated in 1989, Sudeep Pharma Limited is a manufacturer of pharmaceutical excipients, food-grade minerals, and specialty nutrition ingredients serving over 100 countries.

The company operates six manufacturing facilities with a combined production capacity of 50,000 MT, specializing in minerals such as calcium, iron, magnesium, zinc, potassium, and sodium

The company supplies more than 200 products to a diverse customer base across pharma, food, and nutrition sectors

The company has strong R&D capabilities with in-house labs and pilot-scale facilities focused on mineral salts and excipients.

Product Portfolio:

Pharmaceutical, Food and Nutrition Business
Specialty Ingredients Business
Triturates

As of December 31, 2024, the company had 704 permanent employees.

Strength Of Sudeep Pharma IPO

To be announced

Risk Of Sudeep Pharma IPO

To be announced

Objectives Sudeep Pharma IPO

1. Capital expenditure towards procurement of machinery for the production line located at Nandesari Facility I

2. General corporate purposes

Company Contact Details

Sudeep Pharma Limited
129/1/A,
GIDC Estate,
Nandesari,
Vadodara, Gujarat, 391340
Phone: +91 265 284 0656
Email: cs.sudeep@sudeepgroup.com
Website: https://www.sudeeppharma.com/

Registrar Contact Details

Name: MUFG Intime India Private Limited

Phone: +91-22-4918 6270

Email: sudeeppharma.ipo@in.mpms.mufg.com

Website: https://in.mpms.mufg.com/Initial_Offer/public-issues.html

Lead Mangers

ICICI Securities Limited
IIFL Capital Services Limited